The diastolic pulmonary pressure gradient (DPG) has recently been introduced as a specific marker of combined pre-capillary pulmonary hypertension (Cpc-PH) in left heart disease (LHD). However, its diagnostic and prognostic superiority compared with traditional haemodynamic indices has been challenged lately. Current recommendations explicitly denote that in the normal heart, DPG values are greater than zero, with DPG ≥7 mmHg indicating Cpc-PH. However, clinicians are perplexed by the frequent observation of DPG <0 mmHg (DPG NEG ), as its physiological explanation and clinical impact are unclear to date. We hypothesized that large V-waves in the pulmonary artery wedge pressure (PAWP) curve yielding asymmetric pressure transmission might account for DPG NEG 
Introduction
Pulmonary hypertension (PH) is a common complication of left heart disease (LHD). In isolated post-capillary PH, the pulmonary arterial pressure (PAP) elevation is governed solely by the upstream-transmitted left atrial pressure (LAP). Long-standing Traditionally, pulmonary vascular resistance (PVR) and transpulmonary gradient (TPG) have been employed for discerning Cpc-PH, both metrics bearing an established prognostic value in PH due to LHD (PH-LHD). 3, 4 However, as both these markers are influenced by LAP and stroke volume, 5 their specificity has been questioned. In recent times, the diastolic pulmonary pressure gradient (DPG), considered less affected by heart failure (HF)-induced haemodynamic changes, 5 has been introduced as a more reliable Cpc-PH index. Based on the above rationale and study results demonstrating prognostic superiority of the DPG, 6, 7 the Fifth World Symposium on PH proposed that a DPG ≥7 mmHg alone should define Cpc-PH. 5 However, the failure of two recent large-scale studies to confirm the prognostic value of DPG 8, 9 raised concerns regarding its use in PH-LHD. 8, 10 Despite the significant prevalence of negative DPG values (DPG NEG ), reportedly varying between 10% and 50%, 8, 11 the physiological background and the potential prognostic implications of DPG NEG have not yet been investigated; rather, DPG NEG has arbitrarily been considered to represent a measurement error. 12 We hypothesized that prominent V-waves in the pulmonary artery wedge pressure (PAWP) recordings might account for the DPG NEG by causing 'asymmetrical' pressure transmission through the pulmonary capillaries, i.e. a backward LAP wave reflection characterized by disproportionate phasic pressure changes. We therefore undertook the present study in order to (i) investigate the impact of V-waves on the DPG and particularly on the occurrence of DPG NEG ; (ii) elucidate the influence of PAWP as compared with direct LAP measurements on the DPG; and (iii) assess the prognostic significance of DPG NEG compared with positive but normal DPG.
Methods

Study population
The study population consisted of 316 patients. A total of 192 patients were enrolled prospectively; 86 consecutive patients with PH due to heart failure (HF) (denoted as PH-LHD in the following) referred for right heart catheterization (RHC) for HF assessment between January and December 2014 were enrolled prospectively at Karolinska University Hospital, while 106 consecutive patients with severe rheumatic mitral valve stenosis (denoted as MS in the following) referred for percutaneous transvenous mitral commissurotomy (PTMC) between January and June 2012 were enrolled again prospectively at the Sri Sathya Sai Institute (Bangalore, India). In addition, 124 consecutive patients with PH-LHD referred for RHC at the Karolinska University Hospital were studied retrospectively. In all PH-LHD cases, medical treatment had been titrated and haemodynamic stabilization achieved at the time of examination. None of the patients included in the study presented with acute coronary syndrome or had undergone cardiac surgery within 1 year before enrolment. In the case of the MS cohort, subjects with >1 grade mitral regurgitation, aortic valve disease, ischaemic heart disease, AF, or hypertension were not included in the study. In the PH-LHD cohort, no specific exclusion criteria were applied, apart from the fact that patients with pressure tracings of inadequate quality (i.e. that would not have allowed reliable and reproducible identification of waveforms) were not included. A flowchart describing patient enrolment and haemodynamic grouping is provided in the Figure S1 . Follow-up data were collected from the Karolinska University Hospital database that is updated centrally; patients were followed until death, cardiac transplantation, or the end of the study period (mean time: 15.6 months). The prognostic value of DPG NEG vs. positive but normal DPG was assessed. The study was approved by the local ethics committee (registration number 2013/1991-32). All prospectively enrolled subjects provided written informed consent. All subjects underwent transthoracic echocardiography and RHC.
Catheterization
Right heart catheterization was performed using a 6 F balloon-tipped fluid-filled Swan-Ganz catheter (Edwards Lifesciences, Irvine, CA, USA) through jugular or femoral vein access. Mean right atrial pressure (RAP M ), diastolic (PAP D ), mean pulmonary artery pressure (PAP M ), mean pulmonary artery wedge pressure (PAWP M ), and right ventricular systolic pressure (RVSP) were recorded under fluoroscopy after calibration with the zero level set at the mid-thoracic line. All pressure tracings were stored in a connected haemodynamic recorder and analysed offline with commercially available software (Xper Information Management, Philips Medical Systems, The Netherlands). Importantly, in order to ensure the uniformity of data acquisition and the standardization of the study, the same investigator (A.M.) participated in RHC for all MS and the majority of PH-LHD patients and performed the analysis of all waveforms at both sites. From the PAWP recordings, the peak V-and A-wave and the PAWP M were obtained. All pressure measurements were averaged from a minimum of five heart cycles at end-expiration. Cardiac output (CO) was measured using Fick's principle. The oxygen consumption was measured breath by breath by a dedicated gas analysis system. In 15 cases, thermodilution was employed.
The PVR, TPG, and DPG were calculated as: PVR = (PAP M -PAWP M )/CO; TPG = PAP M -PAWP M ; and DPG= PAP D -PAWP M , respectively. The difference between TPG and DPG (ΔPG), which equals PAP M -PAP D , was analysed in order to investigate diagnostic discrepancies by the two measures. The right ventricular stroke work index was calculated as RVSWi = (PAP M -RAP M ) × SVi × 0.0136, where SVi denotes the stroke volume index measured as: CO/heart rate (HR)/body surface area. In MS patients, measurements were performed prior to PTMC. For full details of methods, please see the Supplementary material online.
Simultaneous left atrial pressure and pulmonary artery wedge pressure assessment
In 51 MS patients, simultaneous, beat-to-beat, LAP and PAWP tracings were obtained concurrently with RHC. Interatrial septal puncture was performed with an 8 F Mullins' sheath, dilator and a Brockenbrough needle. The LAP was measured directly through the Mullins' sheath used during valvuloplasty. Both transducers were zeroed after careful calibration, pressures were recorded during a 10 sec period and stored for offline analysis.
expressed as mean ± SD or median and interquartile range. Categorical variables were expressed as absolute values and percentage. Comparisons of groups were performed with Mann-Whitney rank-sum test. Correlations were tested by the Pearson's two-tailed test. All tests were performed at 95% confidence intervals (CIs). A P-value of <0.05 was considered statistically significant. Receiver operator characteristic (ROC) curve analysis was performed. Survival was analysed in 127 PH-LHD patients (115 retrospective, 12 prospective) with Kaplan-Meier non-parametric test and compared using a log-rank test. † Univariate and multiple Cox proportional hazards regression models were used to examine the effects of the DPG on patients' survival. Age-, creatinine-, and sex-adjusted survival curve estimates of the DPG were derived from stratified Cox models.
Results
Study population
Of the 316 patients enrolled, 269 (84.5%) demonstrated PH (PAP M ≥25 mmHg). Of these, 256 (MS: 37%) had PH-LHD (PAP M ≥25 mmHg and PAWP M > 15 mmHg). Demographics are presented in Table 1 . Due to the different underlying pathology, the MS and PH-LHD groups were analysed separately. MS patients had higher PAP M , A-and V-waves, and RVSWi compared with the PH-LHD group. However, DPG did not differ between the two groups ( Table 2) .
V-wave influence on the diastolic pulmonary pressure gradient
To evaluate the effect of V-waves on the DPG, we subgrouped the cohort based on the presence of large V-waves, defined as the V-wave exceeding the PAWP M by the arbitrary limit of >10 mmHg as previous investigators have performed. 13 In the 69 cases (45%) with large V-waves (43 MS and 26 PH-LHD patients), the DPG was on average negative and lower (P < 0.05) compared with those with smaller V-waves, despite similar levels of TPG, PVR, PAP, and cardiac index (P > 0.05, for all comparisons; Table 3 ; Supplementary material online, Figure S2) .
A significant inverse correlation between the V-wave and DPG was evident in patients with PVR <3 Wood Units (WU) (r = −0.45, P < 0.001), both in the MS (r = −0.34, P = 0.03) and in the PH-LHD group (r = −0.46, P < 0.001). A weaker, yet statistically significant inverse correlation (r = −0.36; P = 0.01) between the V-wave and DPG was found in patients with a PVR of 3-7 WU. However, this relationship disappeared at higher PVR values (P > 0.05; Figure 1A) . Conversely, no association between the V-wave and TPG was observed (P > 0.05; Figure 1B ). The modest overall correlation between the V-wave and DPG might be ascribed to the divergent association of V-waves with PAP D at higher PAP M and PVR ( Figure 1D ), whereas the association between V-waves and PAWP M was essentially unaltered throughout the examined PAP M and PVR range ( Figure 1C Importantly, in patients with PVR <3 WU, the V-wave showed the strongest correlation with the ΔPG (r = 0.45, P < 0.001 for the whole cohort, r = 0.36, P = 0.005 for PH-LHD; r = 0.6, P = 0.003 for the MS group, Figure 1E) , with a weaker yet significant association of both the absolute and relative V-wave value with ΔPG (r = 0.26 and r = 0.19, respectively; P < 0.05). Conversely, neither the A-wave nor the CO correlated with ΔPG (P > 0.05, in all cases).
The puzzling finding of normal DPG with concomitantly elevated TPG (>12 mmHg) is not unusual. Indeed, in our study 59 patients (23%, MS: 29%), TPG and DPG demonstrated incongruent diagnostics (TPG >12 mmHg, DPG <7 mmHg). Furthermore, DPG NEG with concomitantly elevated TPG (>12 mmHg) occasionally occurs. In our study, we decided to quantify this discrepancy by calculating ΔPG (ΔPG = TPG -DPG). The ΔPG value that leads to discrepant Cpc-PH diagnostics between TPG and DPG NEG is 12 mmHg. In order to examine whether the V-wave amplitude impacted on this discrepancy, we employed ROC analysis in patients with PVR <3 WU. The association between ΔPG and V-wave amplitude is presented in Figure 1E . At an optimal cut-off limit of 30.5 mmHg, V-wave yielded a sensitivity of 85% and a specificity of 70% [area under the curve (AUC) 0.80, 95% CI 0.72-0.88; P < 0.001) for the identification of ΔPG >12 mmHg (Supplementary material online, Figure S3 ). For the whole cohort of patients with PVR <7 WU, the corresponding figures were: AUC 0.73, P < 0.003; 95% CI 0.61-0.84 at an optimal cut-off limit of the V-wave of 31.5 mmHg.
In an attempt to investigate potential non-invasive and clinical determinants of the V-wave amplitude, left atrial end-systolic volume index, LV mass index, internal LV dimensions, as well as the available clinical variables were tested. None of the tested variables, however, was associated with the V-wave (P > 0.05 in all cases).
Negative diastolic pulmonary pressure gradient values
In total, 123 patients (48%) demonstrated DPG NEG (median −3 mmHg; interquartile range −5 to −2 mmHg) with higher prevalence in the MS compared with the PH-LHD group (55% vs. 44%, P < 0.05). MS patients had significantly higher V-waves (P < 0.001, Table 2 ). When the whole study population was considered, patients with DPG NEG showed significantly larger V-waves and lower PAP M , RAP M , PVR, and TPG values, whereas the PAWP M and cardiac index levels were comparable with those with positive DPG ( Table 4 ).
Assuming that pre-capillary changes differ between positive DPG and DPG NEG patients, we compared the two groups within a pre-defined PVR range (3-7 WU) in order to ensure a comparatively equivalent degree of pre-capillary alterations between the two groups. Patients with DPG NEG demonstrated higher V-waves in both the MS and PH-LHD groups, and a less prominent right heart dilatation along with better RV function (P < 0.001) as compared with the positive DPG cohort, despite similar PAP M (P > 0.05, Table 4 ; Supplementary material online, Table S1 ). Interestingly, the V-wave amplitude was similar in MS and PH-LHD patients in the DPG NEG group. 
Heart rhythm
When the analysis was confined to the 192 patients with HR < 85 b.p.m., 52% demonstrated DPG NEG . Similarly, when only the 53 patients in AF were considered, DPG NEG was measured in 50%.
Alternative pulmonary artery wedge pressure measurements
As detailed in the Supplementary material online ( DPG NEG as compared with those with positive but normal DPG (0 ≤ DPG <7 mmHg) (Figure 2A ). In the DPG NEG group (n = 57), the combined endpoint was documented in 16 cases (10 deaths and 6 transplantations), while in the 0 ≤ DPG <7 mmHg group (n = 53) the corresponding figures were 24 (14 deaths and 10 transplantations). Finally, in the DPG ≥7 mmHg group (n = 17), eight combined endpoint events were recorded (5 deaths and 3 transplantations). The occurrence of the combined endpoint of death or transplantation was significantly higher for 0 ≤ DPG <7 mmHg both in unadjusted analysis (P < 0.005) and when adjusted for age, creatinine, and ischaemic heart disease ( Figure 2B) . Conversely, neither TPG (cut-off 12 mmHg) nor PVR (cut-off 3 WU) provided significant prognostic information (P = 0.522 and P = 0.718, respectively). Furthermore, combining DPG and TPG (DPG NEG and TPG ≤12 mmHg vs. 0 ≤ DPG <7 mmHg and TPG >12 mmHg) also failed to provide prognostic information (P = 0.223).
Discussion
In the present study, we (i) confirm the high prevalence of DPG NEG in PH-LHD patients; (ii) demonstrate that DPG NEG does not always represent a measurement error, but instead may be ascribed to high V-wave amplitude in patients with relatively low resistance in the pulmonary vascular bed; and (iii) show that DPG NEG is associated with lower mortality as compared with the corresponding group of positive yet not elevated DPG.
In healthy subjects and in patients without DPG values ranging between 0 and 5 mmHg. 5 DPG NEG values have so far been regarded as a measurement bias, ascribed to overwedging or inaccurate PAP D recordings. 5 However, the high DPG NEG prevalence, ranging from 20% in critically ill patients 11, 14 to 35% 8 and up to 50% 15 in PH-LHD patients, calls for a reappraisal of its pathophysiological origin. DPG NEG was found in 44% of our PH-LHD cohort, most probably reflecting the higher proportion of PH (95%) compared with that (45%) reported in a recent study. 
V-wave influence on the diastolic pulmonary pressure gradient
During systole, the second phase of LA filling occurs, yielding the most prominent positive deflection of the PAWP waveform designated as the V-wave. The volume and the rate of blood entering the left atrium as well as this chamber's compliance determine the V-wave amplitude, 16, 17 which in healthy subjects averages 12 mmHg, ranging between 4 and 19 mmHg, being at most 6 mmHg higher than LAP M .
18 Importantly, the LA volume-pressure relationship follows an exponential rather than a linear pattern, so that at lower LAP a certain volume entering the left atrium yields minor pressure elevation, whereas at higher LAP an equal inflowing volume results in a greater pressure rise. 13, 16 Conceivably, large V-waves arise not only in the presence of severe acute mitral regurgitation 19 but also in conditions such as MS 20 and longstanding LV dysfunction, when LA distensibility is impaired, resulting in an upward shift of the LA volume-pressure curve. In our study, large V-waves were present in 20% of the PH-LHD group and in 46% of the MS cohort, similar to the findings of Wang and colleagues. 20 It should be emphasized that the augmented V-waves in these two cohorts represent distinct haemodynamic conditions; in MS it reflects increased LA stiffness due to obstructed mitral valve orifice, whereas in PH-LHD it is mainly secondary to a rise in LV end-diastolic pressure (LVEDP). It has been shown that the distorted LAP waveform in the presence of large V-waves leads to overestimation of the LVEDP. 21 Furthermore, there is evidence of retrograde superimposition of prominent V-waves on the PAP contour. 22 Caro and colleagues demonstrated that at high LAP, the ratio of pulmonary arterial to pulmonary venous compliance changes, promoting an asymmetrical backward transmission of the phasic LAP. 23 Although studies concomitantly reporting V-wave amplitude and PAP D are infrequent, the existing data on large V-waves in the context of increased LA stiffness reveal DPG NEG in essentially all cases.
17 Importantly, we demonstrate that the inverse correlation between the V-wave and DPG was confined to patients with relatively low PVR, in accordance with the findings of Falicov and colleagues. 15 Under physiological conditions, at end-diastole, the pulmonary vascular bed allows pressure equilibration 24 otherwise hindered by the presence of vascular remodelling. Taken together, our results indicate that in PH-LHD the V-wave amplitude significantly influences the DPG calculation unless significant pre-capillary remodelling is present. However, with progressive maladaptive pre-capillary alterations, the V-wave no longer acts as an important determinant of the DPG, which might be explained by increased stiffening of the pulmonary arteries and thus dampening of the backward LAP transmission. Previous investigations suggest that large V-waves inversely correlate with the ratio between systolic and diastolic pulmonary inflow velocities. 25 In accordance with previous investigators, LA volume was not associated with V-wave amplitude. 26 As echocardiography plays a key role in the initial PH assessment in HF, further studies are warranted to address potential incremental value of this modality.
Methodological considerations
The current findings argue against the notion that DPG NEG represents merely an inaccurate measurement. First, the PAWP and PAP waveforms were assessed manually at end-expiration by a single investigator, limiting the possibility of erroneous computerized PAP D measurements and preventing potential PAWP M underestimation due to pressure averaging throughout the respiratory cycle. 27 Experimental studies have shown that HR impacts on DPG; at higher HR, DPG rises due to lower LVEDP and a concomitant PAP D elevation. 28 Our results reveal that even when confining the analysis to patients with normal HR or patients with AF, the incidence of DPG NEG was unaltered. Finally, our simultaneously performed PAWP and LAP measurements partly contradict the opinion that DPG would be a result of erroneous PAWP recordings. Direct LAP measurements yielded slightly higher DPG values as compared with PAWP. In ∼11% cases with negative DPG PAWP , the corresponding DPG LAP was positive, while in one case reclassification occurred in the opposite direction (4.5%). This finding points to the fact that due to its low absolute value, even a small measurement error will affect the DPG value; however, it also demonstrates that measurement error accounts for only a minority of DPG NEG cases. Taken together, although the slight discrepancy between LAP and PAWP might account for a minor portion of the DPG NEG , our findings suggest that DPG NEG values can for the most part be ascribed to the augmented V-waves.
Prognostic significance
The prognostic impact of DPG NEG is as yet unknown. It has been suggested that patients with DPG NEG , instead of being a subclass of the isolated post-capillary PH (DPG <7 mmHg) group, in fact represent a cohort with worse haemodynamics. 8 Our findings contradict this hypothesis. We demonstrate that when comparing DPG NEG patients with those with 0 ≤ DPG <7 mmHg, within a pre-defined range of PVR (3-7 WU), the DPG NEG cohort is characterized by lower RAP, and higher tricuspid annular plane systolic excursion (TAPSE), reflecting a state of less pronounced right heart loading and remodelling advocating for milder haemodynamic derangements in the DPG NEG group. This, together with the lower event rate in the DPG NEG as compared with the DPG 0-7 mmHg cohort further supports the concept that DPG NEG in large part results from high V-waves shifting the DPG towards lower values, and suggests limited pre-capillary changes.
In our study, neither PVR nor TPG was associated with worse outcome. Furthermore, combining TPG and PVR with DPG failed to demonstrate significant prognostic value (P = 0.223 and P = 0.195, respectively). This observation stands in contrast to previous results and might be partly related to differences in patient profile. Indeed, as compared with the report by Tampakakis et al., the occurrence of ischaemic heart disease was much higher in our study; 8 additionally, our patient cohort comprised older patients than those studied by Tampakakis et al. or Tedford et al. 8, 9 Finally, the follow-up period was shorter in our study. The constellation of the aforementioned issues as well as the fact that our study comprised fewer patients might account for this discrepancy. However, all studies in India were performed in the presence of A.M. who was responsible for the standardization of the studies in the two centres; additionally, the same technical equipment and catheters were used at both sites. Patient characteristics as well as haemodynamics of the two studied cohorts are also rather divergent, as demonstrated in Table 1 (e.g. patients with AF, hypertension, or ischaemic heart disease were excluded from the MS but not the PH-LHD group); however, as the objective of the present study was not to assess the influence of AF or other co-morbidities on the DPG, but rather to assess the effect of V-wave amplitude on DPG measurement, we believe that despite the patients' heterogeneity, the haemodynamic essence of our hypothesis is still addressed. Our cohort comprised patients with PH-LHD (including both preserved and reduced EF) and MS, in which respect it is different from previous comparable studies. Indeed, pre-capillary involvement as defined by DPG ≥7 mmHg was more frequent in MS patients (20.2%). However, the prevalence of Cpc-PH in the PH-LHD group was 13.6% that is comparable with previous studies (8-16%). 6, 8, 9 Finally, the current study was performed on haemodynamically stable patients, implying that our findings might not be valid in a state of decompensated acute HF.
Limitations
Conclusion
The present study verifies the recently observed high frequency of DPG NEG . We propose an applicable physiological explanation for this haemodynamic finding demonstrating a significant inverse association of V-wave amplitude in the PAWP waveform with the DPG in patients with low PVR. Using direct LAP measurements, we show that the occurrence of DPG NEG is clearly not reflecting methodological inaccuracies; rather it largely represents the augmented disproportionate phasic LAP transmission. Finally, DPG NEG in patients with PH-LHD appears to be associated with milder haemodynamic derangements and better 2-year prognosis compared with patients with DPG within the normal positive range.
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